Regeneron Secures $4.5 Billion Worth of Contracts from the US for Combating COVID-19
By Vicky Su On July 7th, 2020, Regeneron Pharmaceuticals, Inc. announced that the Trump administration has awarded them a $4.5 billion contract to manufacture and supply REGN-COV2, an investigational antibody …
Read More